5F-AMB
Chemical compound From Wikipedia, the free encyclopedia
5F-AMB (also known as 5F-MMB-PINACA and 5F-AMB-PINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family,[2] which has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in early 2014.[3][4] Although only very little pharmacological information about 5F-AMB itself exists,[5] its 4-cyanobutyl analogue (instead of 5-fluoropentyl) has been reported to be a potent agonist for the CB1 receptor (KI = 0.7 nM).[6][7]
| |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H26FN3O3 |
| Molar mass | 363.433 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Side effects
5F-AMB intoxication caused one fatality on its own,[8] another through ketoacidosis in combination with AB-CHMINACA, AB-FUBINACA, AM-2201, 5F-APINACA, EAM-2201, JWH-018, JWH-122, MAM-2201, STS-135 and THJ-2201 and another fatality in combination with AB-CHMINACA and Diphenidine.[9][10]
Legality
In the United States, 5F-AMB is a Schedule I controlled substance.[11]
5F-AMB is an Anlage II controlled substance in Germany as of May 2015.[12]
Sweden's public health agency suggested classifying 5F-AMB as hazardous substance on November 10, 2014.[13]
The state of Louisiana banned 5F-AMB through an emergency rule after it was detected in a synthetic cannabinoids product called "Kali Berry 2" on 3 June 2014.[14]
5F-AMB is controlled by the Fifth Schedule of the Misuse of Drugs Act (MDA) in Singapore as of May 2015.[15]
5F-AMB was also scheduled in Japan on July 25, 2014.[16]
As of October 2015 5F-AMB is a controlled substance in China.[17]
In December 2019, the UNODC announced scheduling recommendations placing 5F-MMB-PINACA as a Schedule II controlled research chemical.[18]
See also
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.